Treatment of Narcolepsy with Coexisting Migraine Headache

Clinical scenario

This protocol covers the management of narcolepsy in a patient who also has migraine headache. Beyond excessive daytime sleepiness (EDS), narcolepsy can itself trigger migraines. When both conditions are present, medication selection must minimise adverse effects on either condition.

Treatment approach — partial overview

Agent choice in this scenario is guided by the headache adverse-effect profile of available wakefulness-promoting medications. Solriamfetol is selected because headache is a relatively uncommon adverse effect and it does not interact with hormonal contraception; other commonly used agents in this class are avoided due to their headache incidence. The complete titration schedule, clinical decision algorithm, and full set of options are in the structured protocol.

Treatment goals

Reduction in excessive daytime sleepiness without increased headache frequency or severity.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.9740/mhc.2025.12.258

In addition to EDS, narcolepsy can trigger migraines.
When managing a patient with coexisting narcolepsy and migraines, the negative effect of medications on either condition should be minimized.
In comparison, headache is a relatively uncommon AE of solriamfetol.
Based on clinical experience, solriamfetol may be a reasonable option in patients without cataplexy.
Armodafinil was changed to solriamfetol because of headache incidence.

View source ↗